ketoconazole has been researched along with tribromoethanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Huang, H; Kalpana, GV; Locker, J; Mani, S; Redinbo, MR; Sinz, M; Staudinger, J; Teotico, DG; Wang, H; Zoeckler, M | 1 |
2 other study(ies) available for ketoconazole and tribromoethanol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Constitutive Androstane Receptor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Ethanol; Female; Gene Expression Regulation; Hepatocytes; Histone Acetyltransferases; Humans; Ketoconazole; Liver X Receptors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Coactivator 1; Orphan Nuclear Receptors; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured | 2007 |